Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 1:02 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS & CO. LLC | 3,297,270 6.600% | 3,297,270 (New Position) | Filing History |
| 2021-02-12 09:32 am Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,009,768 9.260% | 230,633 (+4.83%) | Filing History |
| 2021-02-11 07:51 am Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,550,062 8.410% | -21,257 (-0.47%) | Filing History |
| 2021-02-10 3:12 pm Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Jennison Associates LLC | 2,616,473 4.800% | -14,153 (-0.54%) | Filing History |
| 2021-02-09 5:00 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 3,204,196 6.400% | 3,204,196 (New Position) | Filing History |
| 2021-02-09 1:02 pm Sale | 2021-02-09 | 13G | ProQR Therapeutics N.V. PRQR | PRUDENTIAL FINANCIAL INC PRU | 2,616,473 4.840% | -14,153 (-0.54%) | Filing History |
| 2021-02-03 1:22 pm Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Wellington Management Group LLP | 3,455,765 6.390% | -2,039,363 (-37.11%) | Filing History |